2026Eki
IDXX Oct 2026 · Sell
IDEXX Laboratories Inc. (NASDAQ: IDXX) is rated Sell as the equity trades well above fundamental business value. While the company's proprietary razor-blade diagnostic model commands strong pricing power and high customer retention, prevailing market valuations discount unsustainable compounding that leaves investors exposed to severe multiple contraction.Latest published research · analyzed 2026-10-22 · current · sources aging